News
Home/ News
Changing one letter does not always create a new brand. That is the key lesson from the recent Australian Trade Marks Office decision involving GHOST and GHXST.
AI development contracts in Australia need to do more than describe the software being built. They need to deal with data, privacy, copyright, ownership, testing, security and who is responsible if the tool gets it wrong.
If your product, app or service excludes people, that may be more than an ethical issue. It may be a product weakness, a brand weakness and a missed commercial opportunity.
Some product names are more than names. Champagne. Darjeeling. Stilton. Parma. Pisco. These names point to place, reputation and authenticity. That is why geographical indications, or GIs, matter.
This Australian Made Week, we want to take a moment to celebrate the people building, creating, designing, inventing, and growing businesses right here in Australia.
Business name. Domain name. Trade Mark. They sound similar — but legally, they’re completely different.
Artificial intelligence is no longer a future concept in the pharmaceutical sector. It is already reshaping how new drugs are discovered, designed, tested and manufactured — and that shift is creating major opportunities for businesses working in life sciences, biotech and medical innovation.
For years, luxury brands have relied on a familiar formula: strong storytelling, prestige, heritage, and exclusivity. But the growing popularity of “dupes” suggests the market is becoming less willing to accept those claims at face value.
If a business registers a domain name built around someone else’s brand, a disclaimer at the bottom of the page may not be enough to get it out of trouble. That is the practical message from a recent .au domain name decision involving marena.com.au, where the panel ordered the domain be transferred after finding it had been used in bad faith.
